The overall purpose of the research program is a further understanding of the neurochemical basis of drug abuse. In particular, the experimental approach consists of two objectives: 1) To gain insight into the regulatory functions of the neuronal systems that mediate drug reinforcement, and 2) to determine the effects of repeated exposure to either cocaine or amphetamine on these systems. It is anticipated that the convergence of these two strategies will generate knowledge required for the rationale development of clinically useful, therapeutic agents capable of decreasing the craving and or reward associated with drugs of abuse. The proposed studies constitute a program to examine the interaction of serotonin and dopamine with each other and their response to drugs of abuse such as cocaine, amphetamine, and MDMA. The studies involve protocols to examine transmitter release and synthesis utilizing brain slices (in vitro) and microdialysis (in vivo). The specific objectives set forth to investigate the above issues are: A) What is the pharmacological basis mediating the serotonin (5HT)- facilitation of dopamine (DA) release at the level of the nerve terminal. Additionally, experiments are designed to elucidate the second messenger system of the 5HT receptor and to determine potential involvement of either potassium or calcium fluxes. Subsequent experiments focus on the role of endogenous 5HT on DA release, and systemically administered 5HT agonists on both DA release and synthesis. Finally, does chronic cocaine alter the efficacy of 5HT to facilitate DA release. B) The second major goal of the proposal tests the possibility that DA autoreceptors are the functional counterpart of the recently discovered D3 receptor. In vitro (brain slices) and in vivo protocols are presented to characterize the pharmacological actions of selective DA agonists and antagonists at DA autoreceptors. Lastly, experiments are proposed to discover if repeated exposure to either cocaine or amphetamine modify the functional responsivity of nerve terminal DA autoreceptors.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004120-11
Application #
2733496
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1986-07-01
Project End
2000-06-30
Budget Start
1998-08-15
Budget End
2000-06-30
Support Year
11
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Wayne State University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Chapman, Mary Ann; Roll, John M; Park, Samuel et al. (2003) Extracellular glutamate decrease in accumbens following cued food delivery. Neuroreport 14:991-4
West, A R; Galloway, M P (1998) Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms. Neurochem Int 33:493-501
West, A R; Galloway, M P (1997) Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms. Neuropharmacology 36:1571-81
West, A R; Galloway, M P (1997) Inhibition of glutamate reuptake potentiates endogenous nitric oxide-facilitated dopamine efflux in the rat striatum: an in vivo microdialysis study. Neurosci Lett 230:21-4
Koch, S; Galloway, M P (1997) MDMA induced dopamine release in vivo: role of endogenous serotonin. J Neural Transm 104:135-46
West, A R; Galloway, M P (1996) Intrastriatal infusion of (+/-)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats. J Neurochem 66:1971-80
Aretha, C W; Galloway, M P (1996) Dopamine autoreceptor reserve in vitro: possible role of dopamine D3 receptors. Eur J Pharmacol 305:119-22
West, A R; Galloway, M P (1996) Regulation of serotonin-facilitated dopamine release in vivo: the role of protein kinase A activating transduction mechanisms. Synapse 23:20-7
Galloway, M P; Suchowski, C S; Keegan, M J et al. (1993) Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse 15:90-2
Benloucif, S; Keegan, M J; Galloway, M P (1993) Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther 265:373-7

Showing the most recent 10 out of 18 publications